May 15, 2008
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C...
It is the leading cause of cirrhosis and liver cancer, and the number one reason for liver transplants in . via Rehab Management
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Wall Street Must-Know Zyprexa News | Aug 3 | Jail 4 Lilly | 1 |
| `Exercise in a pill' looms in the future | Aug 2 | Taylor | 1 |
| Vytorin | Jul 31 | Paulette Rogers | 3 |
| Doctors Urge Use Of Statins For Cholesterol -- ... | Jul 28 | Moy Paterson | 4 |
| Vytorin: A Setback For Merck And Schering | Jul 23 | Well of course | 3 |
| New Jersey: Cholesterol pill fails to lower risks | Jul 22 | Hard Boiled Egg | 1 |
| Cholesterol drug of no use in study (from Jan '08) | Jul '08 | DKut | 2 |

